576 related articles for article (PubMed ID: 30278123)
1. Catch and Release Photosensitizers: Combining Dual-Action Ruthenium Complexes with Protease Inactivation for Targeting Invasive Cancers.
Arora K; Herroon M; Al-Afyouni MH; Toupin NP; Rohrabaugh TN; Loftus LM; Podgorski I; Turro C; Kodanko JJ
J Am Chem Soc; 2018 Oct; 140(43):14367-14380. PubMed ID: 30278123
[TBL] [Abstract][Full Text] [Related]
2. Photosensitive Ru(II) Complexes as Inhibitors of the Major Human Drug Metabolizing Enzyme CYP3A4.
Toupin N; Steinke SJ; Nadella S; Li A; Rohrabaugh TN; Samuels ER; Turro C; Sevrioukova IF; Kodanko JJ
J Am Chem Soc; 2021 Jun; 143(24):9191-9205. PubMed ID: 34110801
[TBL] [Abstract][Full Text] [Related]
3. Ruthenium-Cathepsin Inhibitor Conjugates for Green Light-Activated Photodynamic Therapy and Photochemotherapy.
Denison M; Garcia SP; Ullrich A; Podgorski I; Gibson H; Turro C; Kodanko JJ
Inorg Chem; 2024 Apr; 63(17):7973-7983. PubMed ID: 38616353
[TBL] [Abstract][Full Text] [Related]
4. Design of a Tris-Heteroleptic Ru(II) Complex with Red-Light Excitation and Remarkably Improved Photobiological Activity.
Li S; Zhao J; Wang X; Xu G; Gou S; Zhao Q
Inorg Chem; 2020 Aug; 59(15):11193-11204. PubMed ID: 32702972
[TBL] [Abstract][Full Text] [Related]
5. π-Expansive Heteroleptic Ruthenium(II) Complexes as Reverse Saturable Absorbers and Photosensitizers for Photodynamic Therapy.
Wang L; Yin H; Jabed MA; Hetu M; Wang C; Monro S; Zhu X; Kilina S; McFarland SA; Sun W
Inorg Chem; 2017 Mar; 56(6):3245-3259. PubMed ID: 28263079
[TBL] [Abstract][Full Text] [Related]
6. Dual-Action Ru(II) Complexes with Bulky π-Expansive Ligands: Phototoxicity without DNA Intercalation.
Toupin NP; Nadella S; Steinke SJ; Turro C; Kodanko JJ
Inorg Chem; 2020 Mar; 59(6):3919-3933. PubMed ID: 32096986
[TBL] [Abstract][Full Text] [Related]
7. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB
Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686
[TBL] [Abstract][Full Text] [Related]
8. Substituent effect and wavelength dependence of the photoinduced Ru-O homolysis in the [Ru(bpy)2(py-SO3)](+)-type complexes.
Zheng Y; Zhou QX; Zhang YY; Li C; Hou YJ; Wang XS
Dalton Trans; 2016 Feb; 45(7):2897-905. PubMed ID: 26752625
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic antitumor activity of Ru(ii) complexes of imidazo-phenanthroline conjugated hydroxybenzoic acid as tumor targeting photosensitizers.
Liu ZY; Zhang J; Sun YM; Zhu CF; Lu YN; Wu JZ; Li J; Liu HY; Ye Y
J Mater Chem B; 2020 Jan; 8(3):438-446. PubMed ID: 31833531
[TBL] [Abstract][Full Text] [Related]
10. Visible-Light-Responsive Novel Ru(II)-Metallo-Antibiotics with Potential Antibiofilm and Antibacterial Activity.
Mandal AA; Upadhyay A; Mandal A; Nayak M; K MS; Mukherjee S; Banerjee S
ACS Appl Mater Interfaces; 2024 Jun; 16(22):28118-28133. PubMed ID: 38783713
[TBL] [Abstract][Full Text] [Related]
11. New Ru(II) complexes for dual photoreactivity: ligand exchange and (1)O2 generation.
Knoll JD; Albani BA; Turro C
Acc Chem Res; 2015 Aug; 48(8):2280-7. PubMed ID: 26186416
[TBL] [Abstract][Full Text] [Related]
12. New Ru(ii) complex for dual photochemotherapy: release of cathepsin K inhibitor and
Rohrabaugh TN; Collins KA; Xue C; White JK; Kodanko JJ; Turro C
Dalton Trans; 2018 Aug; 47(34):11851-11858. PubMed ID: 29741184
[TBL] [Abstract][Full Text] [Related]
13. Ruthenium(II) complexes as bioorthogonal two-photon photosensitizers for tumour-specific photodynamic therapy against triple-negative breast cancer cells.
Lin M; Zou S; Liao X; Chen Y; Luo D; Ji L; Chao H
Chem Commun (Camb); 2021 May; 57(36):4408-4411. PubMed ID: 33949487
[TBL] [Abstract][Full Text] [Related]
14. Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy.
Heinemann F; Karges J; Gasser G
Acc Chem Res; 2017 Nov; 50(11):2727-2736. PubMed ID: 29058879
[TBL] [Abstract][Full Text] [Related]
15. Photophysical Properties and Photobiological Activities of Ruthenium(II) Complexes Bearing π-Expansive Cyclometalating Ligands with Thienyl Groups.
McCain J; Colón KL; Barrett PC; Monro SMA; Sainuddin T; Roque Iii J; Pinto M; Yin H; Cameron CG; McFarland SA
Inorg Chem; 2019 Aug; 58(16):10778-10790. PubMed ID: 31386351
[TBL] [Abstract][Full Text] [Related]
16. Tuning Polyamidoamine Design To Increase Uptake and Efficacy of Ruthenium Complexes for Photodynamic Therapy.
Mascheroni L; Dozzi MV; Ranucci E; Ferruti P; Francia V; Salvati A; Maggioni D
Inorg Chem; 2019 Nov; 58(21):14586-14599. PubMed ID: 31618015
[TBL] [Abstract][Full Text] [Related]
17. A nuclear permeable Ru(ii)-based photoactivated chemotherapeutic agent towards a series of cancer cells: in vitro and in vivo studies.
Tian N; Feng Y; Sun W; Lu J; Lu S; Yao Y; Li C; Wang X; Zhou Q
Dalton Trans; 2019 May; 48(19):6492-6500. PubMed ID: 30994660
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the mechanisms of action and subcellular localization of ruthenium(II)-based photosensitizers.
Mo J; Mai Le NP; Priefer R
Eur J Med Chem; 2021 Dec; 225():113770. PubMed ID: 34403979
[TBL] [Abstract][Full Text] [Related]
19. Kinetically labile ruthenium(II) complexes of terpyridines and saccharin: effect of substituents on photoactivity, solvation kinetics, and photocytotoxicity.
Kumar P; Singh P; Saren S; Pakira S; Sivakumar S; Patra AK
Dalton Trans; 2021 Jun; 50(23):8196-8217. PubMed ID: 34031678
[TBL] [Abstract][Full Text] [Related]
20. Polyphosphoester-stabilized cubosomes encapsulating a Ru(II) complex for the photodynamic treatment of lung adenocarcinoma.
Casula L; Elena Giacomazzo G; Conti L; Fornasier M; Manca B; Schlich M; Sinico C; Rheinberger T; Wurm FR; Giorgi C; Murgia S
J Colloid Interface Sci; 2024 Sep; 670():234-245. PubMed ID: 38761576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
